CFH基因功能丧失突变影响选择性编码的FHL-1蛋白导致显性早发性黄斑玻璃膜疣
本研究通过多中心病例系列、体外实验及既往变异回顾,对7个显性早发黄斑玻璃膜疣(EOMD)家系进行基因与功能分析,发现超罕见CFH变异致病,重组FHL-1突变蛋白不分泌,提示FHL-1单倍剂量不足是EOMD重要机制,EOMD是AMD的严重亚型。
要点
- EOMD患者均双眼玻璃膜疣,最早发病16岁,中位46岁。
- 7个家系均检出超罕见CFH变异,多数影响补体调控蛋白结构域2-7。
- 重组FHL-1突变蛋白不分泌,功能丧失;75.8%既往EOMD变异影响FHL-1和FH。
核心结论
- EOMD是AMD表型严重的亚型,FHL-1单倍剂量不足可能是部分病例的重要致病机制。
研究设计与样本
- 多中心病例系列、体外实验及对既往报道变异的回顾性分析,纳入7个显性EOMD家系。
主要发现
- 所有受累者均双眼玻璃膜疣,最早发病年龄16岁,中位46岁。
- 每个家系均检出超罕见CFH变异(MAF≤0.0001)。
- 重组FHL-1 R127H、A415f/s、C431S蛋白不分泌,为功能丧失蛋白。
- 回顾29个既往EOMD致病变异,75.8%(22/29)影响FHL-1和FH,86.2%(25/29)导致FH或FHL-1单倍剂量不足。
关键数值与推荐
- 超罕见变异定义为次要等位基因频率(MAF)≤0.0001。
- 所有突变影响补体调控蛋白结构域2至7,预测影响FHL-1和FH。
临床怎么用
- 对早发黄斑玻璃膜疣患者可考虑CFH基因检测,以识别EOMD。
- EOMD与AMD病理相似,其分子机制认识有助于理解AMD发病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To characterize the molecular mechanism underpinning early-onset macular drusen (EOMD), a phenotypically severe subtype of age-related macular degeneration (AMD), in a subgroup of patients. DESIGN: Multicenter case series, in vitro experimentation, and retrospective analysis of previously reported variants. PARTICIPANTS: Seven families with apparently autosomal dominant EOMD. METHODS: Patients underwent a comprehensive ophthalmic assessment. Affected individuals from families A, B, and E underwent whole exome sequencing. The probands from families C, D, F, and G underwent Sanger sequencing analysis of the complement factor H (CFH) gene. Mutant recombinant factor H like-1 (FHL-1) proteins were expressed in HEK293 cells to assess the impact on FHL-1 expression and function. Previously reported EOMD-causing variants in CFH were reviewed. MAIN OUTCOME MEASURES: Detailed clinical phenotypes, genomic findings, in vitro characterization of mutation effect on protein function, and postulation of the pathomechanism underpinning EOMD. RESULTS: All affected participants demonstrated bilateral drusen. The earliest reported age of onset was 16 years (median, 46 years). Ultra-rare (minor allele frequency [MAF], ≤0.0001) CFH variants were identified as the cause of disease in each family: CFH c.1243del, p.(Ala415ProfsTer39) het; c.350+1G→T het; c.619+1G→A het, c.380G→A, p.(Arg127His) het; c.694C→T p.(Arg232Ter) het (identified in 2 unrelated families in this cohort); and c.1291T→A, p.(Cys431Ser). All mutations affect complement control protein domains 2 through 7, and thus are predicted to impact both FHL-1, the predominant isoform in Bruch's membrane (BrM) of the macula, and factor H (FH). In vitro analysis of recombinant proteins FHL-1R127H, FHL-1A415f/s, and FHL-1C431S demonstrated that they are not secreted, and thus are loss-of-function proteins. Review of 29 previously reported EOMD-causing mutations found that 75.8% (22/29) impact FHL-1 and FH. In total, 86.2% (25/29) of EOMD-associated variants cause haploinsufficiency of FH or FHL-1. CONCLUSIONS: Early-onset macular drusen is an underrecognized, phenotypically severe subtype of AMD. We propose that haploinsufficiency of FHL-1, the main regulator of the complement pathway in BrM, where drusen develop, is an important mechanism underpinning the development of EOMD in a number of cases. Understanding the molecular basis of EOMD will shed light on AMD pathogenesis given their pathologic similarities.
引用
- Taylor RL, Poulter JA, Downes SM, et al. Loss-of-Function Mutations in the CFH Gene Affecting Alternatively Encoded Factor H-like 1 Protein Cause Dominant Early-Onset Macular Drusen. Ophthalmology. 2019. PMID: 30905644. doi:10.1016/j.ophtha.2019.03.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。